Borges AH, Russell M, Tait D, Scriba TJ, et al. Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlle Lancet Infect Dis 2025 Mar 5:S1473-3099(24)00814.
PMID: 40056922